Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10457776 | 0.92 | FBP1 (0.36) | FBP1RNASEL | |
| SCHEMBL9964288 | 0.92 | FBP1 (0.36) | FBP1RNASEL | |
| SCHEMBL16158825 | 0.92 | FBP1 (0.36) | FBP1RNASEL | |
| SCHEMBL14079604 | 0.91 | FBP1 (0.39) | FBP1RNASEL | |
| SCHEMBL16996706 | 0.91 | FBP1 (0.36) | FBP1RNASEL | |
| SCHEMBL13172425 | 0.91 | FBP1 (0.36) | FBP1RNASEL | |
| SCHEMBL15304342 | 0.89 | FBP1 (0.34) | FBP1RNASEL | |
| SCHEMBL9971200 | 0.89 | FBP1 (0.34) | FBP1RNASEL | |
| SCHEMBL14537394 | 0.89 | FBP1 (0.34) | FBP1RNASEL | |
| SCHEMBL12458447 | 0.87 | FBP1 (0.33) | FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8242258-B2 | 2' protected nucleoside monomers protected with orthoester-type and acyl carbonate groups; solid phase synthesis of RNA, oxidation and deprotecting, removal from the support | AGILENT TECHNOLOGIES, INC. (US) | 2012-08-14 | — | — | US | disclosed |
| US-8202983-B2 | Thiocarbon-protecting groups for RNA synthesis | AGILENT TECHNOLOGIES, INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-20090209479-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | AGILENT TECHNOLOGIES, INC. | 2009-08-20 | — | — | US | disclosed |
| US-20080194502-A1 | Protecting Groups for RNA Synthesis | AGILENT TECHNOLOGIES, INC. | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194502-A1 | Protecting Groups for RNA Synthesis | NSUN2, NSUN3, RNGTT | FBP1 1479/4885RNASEL 14/4885 |
| US-20090209479-A1 | THIOCARBON-PROTECTING GROUPS FOR RNA SYNTHESIS | NSUN3, NSUN2, TRDMT1 | FBP1 1484/4885RNASEL 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.